Aspiriant LLC’s Blackrock BLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$548K Buy
570
+149
+35% +$157K 0.02% 208
2025
Q4
$451K Buy
421
+55
+15% +$60.1K 0.01% 228
2025
Q3
$427K Sell
366
-14
-4% -$15.7K 0.01% 213
2025
Q2
$399K Sell
380
-24
-6% -$22.7K 0.01% 225
2025
Q1
$382K Buy
404
+9
+2% +$8.82K 0.01% 213
2024
Q4
$405K Buy
+395
New +$401K 0.01% 209
2024
Q3
Sell
-366
Closed -$288K 294
2024
Q2
$288K Sell
366
-131
-26% -$102K 0.01% 235
2024
Q1
$414K Sell
497
-13
-3% -$10.4K 0.02% 214
2023
Q4
$414K Buy
510
+39
+8% +$27.2K 0.02% 205
2023
Q3
$304K Buy
471
+34
+8% +$23.7K 0.02% 221
2023
Q2
$302K Buy
+437
New +$293K 0.02% 218
2022
Q1
Sell
-264
Closed -$242K 280
2021
Q4
$242K Buy
+264
New +$241K 0.01% 245
2021
Q3
Sell
-277
Closed -$243K 236
2021
Q2
$243K Buy
+277
New +$234K 0.01% 214
2020
Q4
Sell
-1,066
Closed -$600K 204
2020
Q3
$600K Buy
+1,066
New +$608K 0.05% 142
2020
Q1
Sell
-513
Closed -$260K 191
2019
Q4
$260K Sell
513
-47
-8% -$22.3K 0.02% 182
2019
Q3
$249K Sell
560
-60
-10% -$26.7K 0.02% 193
2019
Q2
$290K Hold
620
0.02% 181
2019
Q1
$265K Sell
620
-200
-24% -$83.9K 0.02% 195
2018
Q4
$320K Buy
820
+65
+9% +$26.6K 0.02% 179
2018
Q3
$355K Hold
755
0.03% 180
2018
Q2
$377K Buy
+755
New +$399K 0.03% 181
2017
Q1
Sell
-850
Closed -$323K 215
2016
Q4
$323K Sell
850
-2,049
-71% -$751K 0.03% 159
2016
Q3
$1.05M Buy
2,899
+1,063
+58% +$387K 0.1% 103
2016
Q2
$635K Sell
1,836
-981
-35% -$345K 0.06% 123
2016
Q1
$959K Buy
+2,817
New +$893K 0.09% 104

Other funds holding BLK

Aspiriant LLC's BLK Position: Q1 2026 in Review

Aspiriant LLC increased its Blackrock (BLK) stake by 35% in Q1 2026, buying an estimated $157K and bringing the position to 570 shares worth $548K. The position accounts for 0.02% of the portfolio, ranked #208.

Aspiriant LLC first reported a position in BLK in Q1 2016 and has held it in 25 quarters since. The position peaked at $1.05M in Q3 2016. 2,319 funds tracked by Wall St. Rank hold BLK as of Q1 2026.

  • Aspiriant LLC held 570 shares of Blackrock worth $548K as of Q1 2026.
  • Aspiriant LLC bought 149 Blackrock shares in Q1 2026, an estimated $157K.
  • Blackrock made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #208 holding.
  • Aspiriant LLC first reported a position in Blackrock in Q1 2016 and has held it in 25 quarters since.
  • Aspiriant LLC's Blackrock position peaked at $1.05M in Q3 2016.
  • 2,319 funds tracked by Wall St. Rank held Blackrock as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.